Skip to main content
. 2024 Mar 21;14(6):656. doi: 10.3390/diagnostics14060656

Table 1.

Patient and procedural characteristics of 2641 patients who underwent ERCP.

Variables Total
Gender (n = 2640) [n (%)]
      Female 1243 (47.1)
      Male 1397 (52.9)
Age (y, n = 2640) [median (IQR)] 66.0 (52.0–76.7)
BMI (kg/m2, n = 2512) [median (IQR)] 25.4 (22.6–28.8)
Native papilla (n = 2640) [n (%)]
      Yes 1491 (56.5)
      No 1133 (42.9)
      Other (e.g., hepaticojejunostomy) 16 (0.6)
Previous EST (n = 2630) [n (%)]
      No 1591 (60.5)
      Biliary EST only 774 (29.4)
      Pancreatic EST only 147 (5.6)
      Biliary and pancreatic EST 118 (4.5)
Anesthetic technique (n = 2632) [n (%)]
      Endoscopist-directed 714 (27.1)
      Anesthesiologist-directed 1918 (72.9)
Indication (n = 3026) [n (%)]
      CBD stone 1084 (35.8)
      Biliary stricture 818 (27.0)
      PSC 321 (10.6)
      Post LCC 116 (3.8)
      Post LTx 84 (2.8)
      Chronic pancreatitis 235 (7.8)
      Acute pancreatitis 89 (2.9)
      Pseudocyst 126 (4.2)
      Other 153 (5.1)
Total cannulation time (min, n = 756) [median (IQR)] 1.08 (0.25–5.67)
Types of interventions (n = 5519) [n (%)]
      Biliary EST 1387 (25.1)
      CBD stone extraction 1033 (18.7)
      Biliary plastic stent placement, exchange, or removal 800 (14.5)
      ERC cytology 691 (12.5)
      Biliary dilatation 407 (7.4)
      Metal stent placement 359 (6.5)
      Pancreatic stent placement, exchange, or removal 259 (4.7)
      Pancreatic EST 190 (3.4)
      Pancreatic dilatation 158 (2.9)
      ERP cytology 62 (1.1)
      Pseudocystogastrostomy 26 (0.5)
      Prophylactic pancreatic stent 29 (0.6)
      Spyglass 56 (1.0)
      Double-balloon ERCP 62 (1.1)
Total procedural time (min, n = 2555) [median (IQR)] 22.0 (15.0–33.0)
Operator of fluoroscopy equipment (n = 2640) [n (%)]
      Endoscopist 2195 (83.1)
      Radiographer 445 (16.9)

ERCP, endoscopic retrograde cholangiopancreatography; BMI, body mass index; EST, endoscopic sphincterotomy; CBD, common bile duct; PSC, primary sclerosing cholangitis; LCC, laparoscopic cholecystectomy; LTx, liver transplantation; IQR, interquartile range; ERC, endoscopic retrograde cholangiography; and ERP, endoscopic retrograde pancreatography.